{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:24:05Z","timestamp":1791239045744,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,1,26]],"date-time":"2012-01-26T00:00:00Z","timestamp":1327536000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s10096-011-1488-3","type":"journal-article","created":{"date-parts":[[2012,1,26]],"date-time":"2012-01-26T05:16:24Z","timestamp":1327554984000},"page":"1647-1652","source":"Crossref","is-referenced-by-count":36,"title":["Microbiological characteristics of clinical isolates of Cryptococcus spp. in Bahia, Brazil: molecular types and antifungal susceptibilities"],"prefix":"10.1007","volume":"31","author":[{"given":"C. S.","family":"Matos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"de Souza Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. S.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. F.","family":"Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,1,26]]},"reference":[{"key":"1488_CR1","doi-asserted-by":"crossref","DOI":"10.1128\/9781555818241","volume-title":"Cryptococcus neoformans","author":"A Casadevall","year":"1998","unstructured":"Casadevall A, Perfect JR (1998) Cryptococcus neoformans. ASM Press, Washington"},{"key":"1488_CR2","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/j.1567-1364.2006.00088.x","volume":"6","author":"KJ Kwon-Chung","year":"2006","unstructured":"Kwon-Chung KJ, Varma A (2006) Do major species concepts support one, two or more species within Cryptococcus neoformans? FEMS Yeast Res 6:574\u2013587","journal-title":"FEMS Yeast Res"},{"key":"1488_CR3","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","volume":"23","author":"JB Park","year":"2009","unstructured":"Park JB, Wannemuehler KA, Marston NG, Pappas PG, Chiller TM (2009) Estimation of the current global burden of cryptococcal meningitis among person living with HIV\/AIDS. AIDS 23:525\u2013530","journal-title":"AIDS"},{"key":"1488_CR4","doi-asserted-by":"publisher","first-page":"17258","DOI":"10.1073\/pnas.0402981101","volume":"101","author":"SE Kidd","year":"2004","unstructured":"Kidd SE, Hagen F, Tscharke RL, Huynh M, Bartlett KH, Fyfe M (2004) A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia Canada). Proc Natl Acad Sci USA 101:17258\u201317263","journal-title":"Proc Natl Acad Sci USA"},{"key":"1488_CR5","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1086\/597306","volume":"199","author":"EJ Byrnes III","year":"2009","unstructured":"Byrnes EJ III, Bildfell R, Frank SA, Mitchell TG, Marr K, Heitman J (2009) Molecular evidence that the Vancouver Island Cryptococcus gattii outbreak has expanded into the United States Pacific Northwest. J Infect Dis 199:1081\u20131086","journal-title":"J Infect Dis"},{"key":"1488_CR6","doi-asserted-by":"publisher","unstructured":"Lockhart SR, Harris J (2010) Cryptococcus gattii: clinical importance and emergence in North America. Curr Fungal Infect Rep. doi: 10.1007\/s12281-010-0021-y","DOI":"10.1007\/s12281-010-0021-y"},{"key":"1488_CR7","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1590\/S0074-02762008000500008","volume":"103","author":"L Trilles","year":"2008","unstructured":"Trilles L, Laz\u00e9ra MS, Wanke B, Oliveira RV, Barbosa GG, Nishikawa MM, Morales BP, Meyer W (2008) Regional pattern of the molecular types of Cryptococcus neoformans and Cryptococcus gattii in Brazil. Mem\u00f3rias do Instituto Oswaldo Cruz 103:455\u2013462","journal-title":"Mem\u00f3rias do Instituto Oswaldo Cruz"},{"key":"1488_CR8","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1590\/S0074-02762009000400023","volume":"104","author":"SPSE Costa","year":"2009","unstructured":"Costa SPSE, Laz\u00e9ra MS, Santos WRA, Morales BP, Bezerra CCF, Nishikawa MM, Barbosa GG, Trilles L, Nascimento JLM, Wanke B (2009) First isolation of Cryptococcus gattii molecular type VGII and Cryptococcus neoformans molecular type VNI from environmental sources in the city of Bel\u00e9m, Par\u00e1, Brazil. Mem\u00f3rias do Instituto Oswaldo Cruz 104:662\u2013664","journal-title":"Mem\u00f3rias do Instituto Oswaldo Cruz"},{"key":"1488_CR9","first-page":"75","volume":"4","author":"JA Alspaugh","year":"2002","unstructured":"Alspaugh JA, Perfect JR (2002) Cryptococcal meningitis. Curr Treat Opin Infect Dis 4:75\u201380","journal-title":"Curr Treat Opin Infect Dis"},{"key":"1488_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1146\/annurev.micro.60.080805.142102","volume":"60","author":"X Lin","year":"2006","unstructured":"Lin X, Heitman J (2006) The biology of the Cryptococcus neoformans species complex. Annu Rev Microbiol 60:69\u2013105","journal-title":"Annu Rev Microbiol"},{"key":"1488_CR11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1086\/649858","volume":"50","author":"JR Perfect","year":"2010","unstructured":"Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, Harrison TS, Larsen RA, Lortholary O, Nguyen M, Pappas PG, Powderly WG, Singh N, Sobel JD, Sorrell TC (2010) Clinical practice guidelines for the management of Cryptococcal disease: 2010\u2014infectious diseases society of America. Clin Infect Dis 50:291\u2013322","journal-title":"Clin Infect Dis"},{"key":"1488_CR12","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1007\/s10096-004-1136-2","volume":"23","author":"J Chandenier","year":"2004","unstructured":"Chandenier J, Adou-Bryn KD, Douchet C, Sar B, Kombila M, Swinne D, Therizol-Ferly M, Buisson Y, Richard-Lenovle D (2004) In vitro activity of amphotericin B, fluconazole, and voriconazole against 162 Cryptococcus neoformans isolates from Africa and Cambodia. Eur J Clin Microbiol Infect Dis 23:506\u2013508","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1488_CR13","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1093\/jac\/dki393","volume":"56","author":"A Perkins","year":"2005","unstructured":"Perkins A, Gomez-Lopez A, Mellado E, Rodriguez-Tudela JL, Cuenca-Estrella M (2005) Rates of antifungal resistance among Spanish clinical isolates of Cryptococcus neoformans var. neoformans. J Antimicrob Chemother 56:1144\u20131147","journal-title":"J Antimicrob Chemother"},{"key":"1488_CR14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1128\/AAC.01216-08","volume":"53","author":"GR Thompson III","year":"2009","unstructured":"Thompson GR III, Wiederhold NP, Fothergill AW, Vallor AC, Wickes BL, Patterson TF (2009) Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans. Antimicrob Agents Chemother 53:309\u2013311","journal-title":"Antimicrob Agents Chemother"},{"key":"1488_CR15","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1128\/AAC.45.11.3065-3069.2001","volume":"45","author":"ME Brandt","year":"2001","unstructured":"Brandt ME, Pfaller MA, Hajjeh RA, Hamill RJ, Pappas PG, Reingold AL, Rimland D, Warnock DW, Cryptococcal Disease Active Surveillance Group (2001) Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998. Antimicrob Agents Chemother 45:3065\u20133069","journal-title":"Antimicrob Agents Chemother"},{"key":"1488_CR16","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1128\/JCM.43.5.2163-2167.2005","volume":"43","author":"MA Pfaller","year":"2005","unstructured":"Pfaller MA, Messer SA, Boyken L, Rice C, Tendolkar S, Hollis RJ, Doern GN, Diekema DJ (2005) Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004). J Clin Microbiol 43:2163\u20132167","journal-title":"J Clin Microbiol"},{"key":"1488_CR17","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1159\/000102585","volume":"53","author":"AI Aller","year":"2007","unstructured":"Aller AI, Claro R, Castro C, Serrano C, Colom MF, Martin-Mazuelos E (2007) Antifungal susceptibility of Cryptococcus neoformans isolates in HIV-infected patients to fluconazole, itraconazole, and voriconazole in Spain: 1994\u20131996 and 1997\u20132005. Chemotherapy 53:300\u2013305","journal-title":"Chemotherapy"},{"key":"1488_CR18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1128\/JCM.01747-08","volume":"47","author":"AM Pfaller","year":"2009","unstructured":"Pfaller AM, Diekema DJ, Gibbs DL, Newell VA, Bijie H, Dzierzanowska D, Klimko NN, Letscher-Bru V, Lisalova M, Muehlethaler K, Rennison C, Zaidi M, and the Global Antifungal Surveillance Group (2009) Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J Clin Microbiol 47:117\u2013123","journal-title":"J Clin Microbiol"},{"key":"1488_CR19","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/S1473-3099(05)70197-3","volume":"5","author":"T Bicanic","year":"2005","unstructured":"Bicanic T, Wood R, Bekker LG, Darder M, Meintjes G, Harrison TS (2005) Antiretroviral roll-out, antifungal roll-back: access to treatment for Cryptococcal meningitis. Lancet Infect Dis 5:530\u2013531","journal-title":"Lancet Infect Dis"},{"key":"1488_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1439-0507.2006.01293.x","volume":"50","author":"CC Bii","year":"2006","unstructured":"Bii CC, Makimura K, Abe S, Taguchi H, Mugasin OM, Revathi G, Wamae N, Kamiya S (2006) Antifungal drug susceptibility of Cryptococcus neoformans from clinical sources in Nairobi, Kenya. Mycoses 50:25\u201330","journal-title":"Mycoses"},{"key":"1488_CR21","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.2307\/3758842","volume":"67","author":"KJ Kwon-Chung","year":"1975","unstructured":"Kwon-Chung KJ (1975) A new genus, Filobasidiella, the perfect state of Cryptococcus neoformans. Mycol 67:1197\u20131200","journal-title":"Mycol"},{"key":"1488_CR22","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1128\/JCM.15.3.535-537.1982","volume":"15","author":"KJ Kwon-Chung","year":"1982","unstructured":"Kwon-Chung KJ, Polacheck I, Bennett JE (1982) Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J Clin Microbiol 15:535\u2013537","journal-title":"J Clin Microbiol"},{"key":"1488_CR23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3201\/eid0902.020246","volume":"9","author":"W Meyer","year":"2003","unstructured":"Meyer W, Castaneda A, Jackson S, Huynh M, Castaneda E, the Ibero American Cryptococcal Study Group (2003) Molecular typing of IberoAmerican Cryptococcus neoformans isolates. Emerg Infect Dis 9:189\u2013195","journal-title":"Emerg Infect Dis"},{"key":"1488_CR24","unstructured":"Clinical Laboratory Standards Institute (CLSI) (2008) Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard, third edition. CLSI document M27-A3. Wayne, PA"},{"key":"1488_CR25","first-page":"221","volume":"1","author":"A Bolano","year":"2001","unstructured":"Bolano A, Stinchi S, Preziosi R, Bistoni F, Allegrucci M, Baldelli F, Martini A, Cardinali G (2001) Rapid methods to extract DNA and RNA from Cryptococcus neoformans. FEMS Yeast Res 1:221\u2013224","journal-title":"FEMS Yeast Res"},{"key":"1488_CR26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3201\/eid1702.101020","volume":"17","author":"L MacDougall","year":"2011","unstructured":"MacDougall L, Fyfe M, Romney M, Starr M, Galanis E (2011) Risk factors for Cryptococcus gattii infection, British Columbia, Canada. Emerg Infect Dis 17:193\u2013199","journal-title":"Emerg Infect Dis"},{"key":"1488_CR27","first-page":"865","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","unstructured":"Centers for Disease Control and Prevention (CDC) (2010) Emergence of Cryptococcus gattii\u2014Pacific Northwest, 2004\u20132010. MMWR Morb Mortal Wkly Rep 59:865\u2013868","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1488_CR28","doi-asserted-by":"crossref","unstructured":"Lester SJ, Malik R, Bartlett KH, Duncan CG (2011) Cryptococcosis; update and emergence of Cryptococcus gattii. Vet Clin Pathol 1\u201314","DOI":"10.1111\/j.1939-165X.2010.00281.x"},{"key":"1488_CR29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1128\/JCM.41.1.73-77.2003","volume":"41","author":"MM Nishikawa","year":"2003","unstructured":"Nishikawa MM, Laz\u00e9ra MS, Barbosa GG, Trilles L, Balassiano BR, Macedo RCL, Bezerra CCF, P\u00e9rez MA, Cardarelli P, Wanke B (2003) Serotyping of 467 Cryptococcus neoformans isolates from clinical and environmental sources in Brazil: analysis of host and regional patterns. J Clin Microbiol 41:73\u201374","journal-title":"J Clin Microbiol"},{"key":"1488_CR30","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1590\/S0074-02762008000800012","volume":"103","author":"WR Santos","year":"2008","unstructured":"Santos WR, Meyer W, Wanke B, Costa SPSE, Trilles L, Nascimento JLM, Medeiros R, Morales BP, Bezerra CCF, Mac\u00eado RCL, Ferreira SO, Barbosa GG, Perez MA, Nishikawa MM, Laz\u00e9ra MS (2008) Primary endemic Cryptococcus gattii by molecular type VGII in the state of Par\u00e1, Brazil. Mem\u00f3rias do Instituto Oswaldo Cruz 103:813\u2013818","journal-title":"Mem\u00f3rias do Instituto Oswaldo Cruz"},{"key":"1488_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1590\/S0036-46652007000100008","volume":"49","author":"MT Matsumoto","year":"2007","unstructured":"Matsumoto MT, Fusco-Almeida AM, Bazea LC, Melhem MSC, Mendes Ginnini MJS (2007) Genotyping, serotyping and determination of mating-type of Cryptococcus neoformans clinical isolates from S\u00e3o Paulo state, Brazil. Revista do Instituto de Medicina Tropical de S\u00e3o Paulo 49:41\u201347","journal-title":"Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"},{"key":"1488_CR32","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1567-1364.2006.00128.x","volume":"7","author":"AMF Almeida","year":"2007","unstructured":"Almeida AMF, Matsumoto MT, Baeza LC, Oliveira e Silva RB, Kleiner AAP, Melhem MSC, Giannini MJSM, the Laboratory Group on Cryptococcosis (2007) Molecular typing and antifungal susceptibility of clinical sequential isolates of Cryptococcus neoformans from Sao Paulo State, Brazil. FEMS Yeast Res 7:152\u2013164","journal-title":"FEMS Yeast Res"},{"key":"1488_CR33","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1590\/S0037-86822008000200005","volume":"41","author":"PR Silva","year":"2008","unstructured":"Silva PR, Rabelo RAS, Terra APS, Teixeira DNS (2008) Susceptibility to antifungal agents among Cryptococcus neoformans varieties isolated from patients at a university hospital. Revista da Sociedade Brasileira de Medicina Tropical 41:158\u2013162","journal-title":"Revista da Sociedade Brasileira de Medicina Tropical"},{"key":"1488_CR34","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1590\/S0037-86822009000600010","volume":"42","author":"OC Favalessa","year":"2009","unstructured":"Favalessa OC, Ribeiro LC, Tadano T, Fontes CJF, Dias FB, Coelho BPA, Hahn RC (2009) First description of phenotypic profile and in vitro drug susceptibility of Cryptococcus spp. yeast isolated from HIV-positive and HIV-negative patients in State of Mato Grosso. Revista da Sociedade Brasileira de Medicina Tropical 42:661\u2013665","journal-title":"Revista da Sociedade Brasileira de Medicina Tropical"},{"key":"1488_CR35","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S1567-1356(03)00038-2","volume":"3","author":"AK Casali","year":"2003","unstructured":"Casali AK, Goulart L, Silva LK Rosa e, Ribeiro AM, Amaral AA, Alves SH, Schrank A, Meyer W, Vainstein H (2003) Molecular typing of clinical and environmental Cryptococcus neoformans isolates in the Brazilian state of Rio Grande do Sul. FEMS Yeast Res 3:405\u2013415","journal-title":"FEMS Yeast Res"},{"key":"1488_CR36","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/13693780310001644743","volume":"42","author":"RP Igreja","year":"2004","unstructured":"Igreja RP, Lazera MS, Wanke B, Galhardo MC, Kidd SE, Meyer W (2004) Molecular epidemiology of Cryptococcus neoformans isolates from AIDS patients of the Brazilian city, Rio de Janeiro. Med Mycol 42:229\u2013238","journal-title":"Med Mycol"},{"key":"1488_CR37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1023\/B:MYCO.0000038435.14281.f4","volume":"158","author":"P Sriburee","year":"2004","unstructured":"Sriburee P, Khayhan S, Khamwan C, Panjaisee S, Tharavichitkul P (2004) Serotype and PCR-fingerprints of clinical and environmental isolates of Cryptococcus neoformans in Chiang Mai, Thailand. Mycopatologia 158:25\u201331","journal-title":"Mycopatologia"},{"key":"1488_CR38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11046-005-6332-9","volume":"160","author":"Y Morera-L\u00f3pez","year":"2005","unstructured":"Morera-L\u00f3pez Y, Torres-Rodr\u00edguez JM, Jim\u00e9nez-Cabello T, Bar\u00f3-Tom\u00e1s T, Al\u00eda-Aponte C, L\u00e1zera MS (2005) DNA fingerprinting pattern and susceptibility to antifungal drugs in Cryptococcus neoformans variety grubii isolates from Barcelona city and rural environmental samples. Mycopathologia 160:9\u201314","journal-title":"Mycopathologia"},{"key":"1488_CR39","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11684-010-0011-z","volume":"4","author":"M Chen","year":"2010","unstructured":"Chen M, Li CY, Wu SX, Tang XT, Feng B, Yao ZR, Pan WH, Liao HQ, Quan ZX (2010) Molecular epidemiology of Cryptococcus neoformans species complex isolates from HIV-positive and HIV-negative patients in southeast China. Front Med China 4:117\u2013126","journal-title":"Front Med China"},{"key":"1488_CR40","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/j.1567-1364.2010.00648.x","volume":"10","author":"YH Choi","year":"2010","unstructured":"Choi YH, Ngamskulrungroj P, Varma A, Sionov E, Hwang SM, Carriconde F, Meyer W, Litvintseva AP, Lee WG, Shin JH, Kim EC, Lee KW, Choi TY, Lee YL, Kwon-Chung KJ (2010) Prevalence of the VNIc genotype of Cryptococcus neoformans in non-HIV-associated cryptococcosis in the Republic of Korea. FEMS Yeast Res 10:769\u2013778","journal-title":"FEMS Yeast Res"},{"key":"1488_CR41","first-page":"792","volume":"43","author":"C Stephen","year":"2002","unstructured":"Stephen C (2002) Multispecies outbreak of cryptococcosis on southern Vancouver Island, British Columbia. Can Vet J 43:792\u2013794","journal-title":"Can Vet J"},{"key":"1488_CR42","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1086\/524071","volume":"46","author":"ZA Kanafani","year":"2008","unstructured":"Kanafani ZA, Perfect JR (2008) Resistance to antifungal agents: mechanisms and clinical impact. Clin Infect Dis 46:120\u2013128","journal-title":"Clin Infect Dis"},{"key":"1488_CR43","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1586\/eri.09.18","volume":"7","author":"J Pem\u00e1n","year":"2009","unstructured":"Pem\u00e1n J, Cant\u00f3n E, Espinel-Ingroff A (2009) Antifungal drug resistance mechanisms. Expert Rev Anti-Infect Ther 7:453\u2013460","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"1488_CR44","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1111\/j.1469-0691.2008.02022.x","volume":"14","author":"A Gomes-Lopez","year":"2008","unstructured":"Gomes-Lopez A, Zaragoza O, Dos Anjos M, Melhem MC, Rodriguez-Tudela JL, Cuenca-Estrella M (2008) In vitro susceptibility of Cryptococcus gattii clinical isolates. Clin Microbiol Infect 14:716\u2013730","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"1488_CR45","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ijantimicag.2008.11.007","volume":"33","author":"ZU Khan","year":"2009","unstructured":"Khan ZU, Randhawa HS, Chehadeh A, Kowshik T, Chandy R (2009) Cryptococcus neoformans serotype A and Cryptococcus gattii serotype B isolates differ in their susceptibilities to fluconazol and voriconazol. Int J Antimicrob Agents 33(6):559\u2013563. doi: 10.1016\/j.ijantimicag.2008.11.007","journal-title":"Int J Antimicrob Agents"},{"key":"1488_CR46","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jac\/dkn132","volume":"62","author":"JM Torres-Rodr\u00edguez","year":"2008","unstructured":"Torres-Rodr\u00edguez JM, Alvarado-Ram\u00edrez E, Murciano F, Sellart M (2008) MICs and minimum fungicidal concentrations of posaconazole, voriconazole and fluconazole for Cryptococcus neoformans and Cryptococcus gattii. J Antimicrob Chemother 62:205\u2013206","journal-title":"J Antimicrob Chemother"},{"key":"1488_CR47","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1128\/JCM.39.6.2348-2350.2001","volume":"39","author":"BM Calvo","year":"2001","unstructured":"Calvo BM, Colombo AL, Fischman O, Santiago A, Thompson L, Lazera M, Telles F, Fukushima K, Nishimura K, Tanaka R, Myiajy M, Moretti-Branchini ML (2001) Antifungal susceptibilities, varieties, and electrophoretic karyotypes of clinical isolates of Cryptococcus neoformans from Brazil, Chile, and Venezuela. J Clin Microbiol 39:2348\u20132350","journal-title":"J Clin Microbiol"},{"key":"1488_CR48","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1046\/j.1439-0507.2003.00872.x","volume":"46","author":"EMP Moraes","year":"2002","unstructured":"Moraes EMP, Pr\u00edmola NS, Hamdan JS (2002) Antifungal susceptibility of clinical and environmental isolates of Cryptococcus neoformans to four antifungal drugs determined by two techniques. Mycoses 46:164\u2013168","journal-title":"Mycoses"},{"key":"1488_CR49","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/clinids\/21.1.28","volume":"21","author":"B Speed","year":"1995","unstructured":"Speed B, Dunt D (1995) Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis 21:28\u201334","journal-title":"Clin Infect Dis"},{"key":"1488_CR50","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s12281-010-0013-y","volume":"4","author":"RH Drew","year":"2010","unstructured":"Drew RH, Townsend ML (2010) Antifungal drug resistance: clinical relevance and impact of antifungal drug use. Curr Fungal Infect Rep 4:129\u2013136","journal-title":"Curr Fungal Infect Rep"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-011-1488-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-011-1488-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-011-1488-3.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-011-1488-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T08:14:15Z","timestamp":1593591255000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-011-1488-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,26]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["1488"],"URL":"https:\/\/doi.org\/10.1007\/s10096-011-1488-3","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,26]]}}}